Comparing two asthma rescue inhalers with different propellants
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study compares two versions of the common asthma rescue inhaler (salbutamol/albuterol) that use different propellants (the gas that pushes the medicine out). The goal is to see if the new propellant works as well as the current one. If you have mild asthma and are on a stable treatment plan, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have had asthma for at least 6 months and it is mild to moderate (your lung function is at least 80% of normal).
- You are on a stable asthma treatment (either a rescue inhaler alone, a low-dose steroid inhaler, or a combination inhaler) for at least 12 weeks.
- You have not had a severe asthma attack in the last 6 months, and no more than one in the last year.
- You are a non-smoker or have not smoked or vaped in the last 12 months, and have less than 10 total pack-years of smoking history.
- You are willing to temporarily stop your rescue inhaler for 12 hours and any long-acting inhaler for 48 hours before study visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares the safety of two different propellants (the gases that push medicine out of inhalers) in people with well-controlled asthma. Researchers want to ensure both propellants are safe to use in asthma inhalers.
This study checks whether a new albuterol inhaler works the same way as a reference inhaler in adults with stable, mild asthma. It may help you (and others) by confirming that the inhaler delivers the right effect and is safe to use.
This trial tests whether a new inhaler (CHF5993) works as well as the current standard for adults with mild to moderate asthma. It compares how well the medicine controls asthma and opens airways.
This trial tests whether a new combination inhaler works as well as a commonly used one for teenagers with asthma that is not well controlled. It aims to find a safe and effective treatment option for adolescents.
This study tests a new inhaler (PT027) against another inhaler (PT007) for teens aged 12 to 17 with asthma. It looks at how well the new inhaler works when used as needed, and if it is safe.
This trial tests a new combination inhaler (QVM149) against a standard one (Advair) in teenagers with asthma that isn't well controlled by their current medicine. It aims to see if the new inhaler works better.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.